Drug Trial Radar · NCT05857566
Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
May 16, 2023
Primary completion
Jul 13, 2023
Study completion Sep 13, 2023
Sponsor
- Lead sponsor
- Response PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- May 12, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This Phase 1b Study RDX-002-22-09 has been planned to evaluate the effect of RDX-002 on postprandial triglycerides and ApoB48 levels in normal healthy subjects treated with the atypical antipsychotic drug, olanzapine.
Conditions
- Drug-induced Weight Gain
Interventions
RDX-002 + OlanzipineDrug
A potent, selective, and gut-specific microsomal triglyceride transfer protein (MTP) inhibitor.
OlanzapineDrug
An FDA-approved atypical (second-generation) antipsychotic medication
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Difference Between the Two Treatment Arms for Postprandial Triglyceride Absolute Area Under the Curve (AUC) on Day 15 vs. Day : 0, 1, 2, 3, 4, 6, and 8 Hours Post DoseTime frame: 7 days
- Mean Absolute Difference Between the Two Treatment Arms for Postprandial Triglyceride Absolute AUC on Day 15 vs. Day : 0, 1, 2, 3, 4, 6, and 8 Hours Post DoseTime frame: 7 days
- Mean Percent Difference Between the Two Treatment Arms for Postprandial Triglyceride Incremental AUC on Day 15 vs. Day : 0, 1, 2, 3, 4, 6, and 8 Hours Post DoseTime frame: 7 days
- Mean Absolute Difference Between the Two Treatment Arms for Postprandial Triglyceride Incremental AUC on Day 15 vs. Day 8: 0, 1, 2, 3, 4, 6, and 8 Hours Post DoseTime frame: 7 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nucleus Network
Saint Paul, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.